BARRY STRAIN: Open Payments
NPI 1346791902 · HILLSDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 58 payments from 20 companies in 2025. Trend: 2023 $836 · 2024 $909 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $198 |
| Viatris Specialty LLC | 3 | $92 |
| Vanda Pharmaceuticals Inc. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Exact Sciences Corporation | 3 | $58 |
| Corcept Therapeutics | 3 | $51 |
| Amgen Inc. | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $33 |
Products named: CAPLYTA, VRAYLAR, YUPELRI, FANAPT, Korlym, Kerendia, TEZSPIRE, REXULTI.
Industry payments across MI — which companies pay providers there.
